BeyondSpring (BYSI) News
NASDAQ: BYSIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
BYSI news summary
We found 2 recent headlines mentioning BeyondSpring (BYSI): 1 in the past week and 2 in the past 30 days, most often from Nasdaq, GlobeNewswire. BYSI is making an outsized move today, down 24.49% at $0.33, which often coincides with company-specific news. Check the latest headlines below for the likely catalyst. The most recent story, "BeyondSpring Turns $50 Mln Profit In Q3 On Sale Of Subsidiary, Plans Phase 3 DUBLIN-4 In China", was published by Nasdaq on Nov 16, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BeyondSpring headlines
- BeyondSpring Turns $50 Mln Profit In Q3 On Sale Of Subsidiary, Plans Phase 3 DUBLIN-4 In China(RTTNews) - The clinical-stage biopharmaceutical company BeyondSpring Inc. (BYSI) released third quarter financial results and noted turning a profit due to income gained on the sale of subsidiary…NasdaqBYSI, LEN.B
- BeyondSpring Reports Third-Quarter 2026 Financial Results and Provides Corporate UpdateFDA Fast Track Designation for Plinabulin plus docetaxel marks key regulatory milestone in DUBLIN-4 study population of Post-ICI Non-Squamous NSCLC with no actionable genomic alteration (AGA)GlobeNewswire